President Donald Trump is reportedly planning to remove Dr. Marty Makary from his role as the U.S. Food and Drug Administration (FDA) chief, a move that follows the agency's recent approval of fruit-flavored e-cigarettes for adults aged 21 and older. This decision marks a significant shift from the FDA's previous stance against vaping. Trump's push for the approval has been linked to his broader campaign to 'make vaping great again.' However, Makary's tenure has been fraught with controversies, drawing criticism from conservative media, pharmaceutical companies, and anti-abortion groups. His handling of key issues, such as the abortion pill safety review and the rejection of a melanoma therapy, has further alienated him from important stakeholders within the administration. The White House is reportedly considering FDA Deputy Commissioner Kyle Diamantas as a potential interim replacement. Dr. Marty Makary has an extensive medical background, having worked at Johns Hopkins University School of Medicine and authored several best-selling books on healthcare transparency.